Search Results

2,478 articles with title/keywords/abstract containing osteoporosis treatment

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days The Impact of Fewer Hip Fractures with Risedronate Versus Alendronate in the First Year of Treatment: Modeled German Cost-Effectiveness Analysis

Authors: Thompson, Melissa; Pasquale, Margaret; Grima, Daniel; Moehrke, Werner; Kruse, Hans Peter

Source: Value in Health, Volume 13, Number 1, January/February 2010 , pp. 46-54(9)

Publisher: Blackwell Publishing

Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α

Authors: Onnis, Valeria; Kinsella, Gemma K; Carta, Giorgio; Fayne, Darren; Lloyd, David G

Source: Future Medicinal Chemistry, Volume 1, Number 3, June 2009 , pp. 483-499(17)

Publisher: Future Science

Secondary prevention of osteoporosis post minimal trauma fracture in an Australian regional and rural population

Authors: Barrack, Cecily M.; McGirr, Ellen E.; Fuller, Jeffrey D.; Foster, Nicola M.; Ewald, Dan P.

Source: Australian Journal of Rural Health, Volume 17, Number 6, December 2009 , pp. 310-315(6)

Publisher: Blackwell Publishing

Drug-induced esophagitis

Authors: Zografos, G. N.; Georgiadou, D.; Thomas, D.; Kaltsas, G.; Digalakis, M.

Source: Diseases of the Esophagus, Volume 22, Number 8, November 2009 , pp. 633-637(5)

Publisher: Blackwell Publishing

Recurrent Duodenal Ulcer Due to Nonsteroidal Anti-Inflammatories Following the Suspension of Antiulcer Medication

Author: >Ana Paula Silva,

Source: Clinical Drug Investigation, Volume 29, Supplement 2, 24 November 2009 , pp. 23-25(3)

Publisher: Adis International

D-Hormone Derivatives for the Treatment of Osteoporosis: From Alfacalcidol to Eldecalcitol

Author: Kubodera, Noboru

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 12, October 2009 , pp. 1416-1422(7)

Publisher: Bentham Science Publishers

Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?

Author: Podgorski, Izabela

Source: Future Medicinal Chemistry, Volume 1, Number 1, April 2009 , pp. 21-34(14)

Publisher: Future Science

Vitamin D status and optimal supplementation in institutionalized adults with intellectual disability

Authors: Kilpinen-Loisa, P.; Arvio, M.; Ilvesmäki, V.; Mäkitie, O.

Source: Journal of Intellectual Disability Research, Volume 53, Number 12, December 2009 , pp. 1014-1023(10)

Publisher: Blackwell Publishing

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Effect of topiramate on acid-base balance: extent, mechanism and effects

Authors: Mirza, Nasir; Marson, Anthony G.; Pirmohamed, Munir

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 655-661(7)

Publisher: Blackwell Publishing

Estimating Medical Expenditure Associated with Osteoporotic Hip Fracture in Elderly Korean Women Based on the National Health Insurance Claims Database 2002-2004

Authors: Kang, Hye-Young; Park, Sung-Eun; Kang, Dae Ryong; Kim, Ji Yoon; Jang, Young Hwa; Choi, Won-Jung; Moon, Seong-Hwan; Yang, Kyu-Hyun; Park, Jin-Young; Kwon, Soon-Yong

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S93-S96(1)

Publisher: Blackwell Publishing

Bone signaling pathways and treatment of osteoporosis

Authors: Gogakos, Apostolos I; Cheung, Moira S; Bassett, JH Duncan; Williams, Graham R

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 639-650(12)

Publisher: Expert Reviews

Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

Authors: Saad, Fred; Abrahamsson, Per-Anders; Miller, Kurt

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1573-1579(7)

Publisher: Blackwell Publishing

Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis

Authors: Planas, Jacques; Trilla, Enrique; Raventós, Carles; Cecchini, Lluis; Orsola, Anna; Salvador, Carles; Placer, Jose; Encabo, Gloria; Morote, Juan

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1637-1640(4)

Publisher: Blackwell Publishing

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Authors: Rabaglio, M.; Sun, Z.; Price, K. N.; Castiglione-Gertsch, M.; Hawle, H.; Thrlimann, B.; Mouridsen, H.; Campone, M.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Pienkowski, T.; Nogaret, J.-M.; Lng, I.; Smith, I.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1489-1498(10)

Publisher: Oxford University Press

Editorial [Hot topic: Polyunsaturated Fatty Acids and Human Health: A Critical Appraisal of the Evidence (Executive Editor: Antonio Cherubini)]

Authors: Cherubini, Antonio; Ruggiero, C.; Lattanzio, F.

Source: Current Pharmaceutical Design, Volume 15, Number 36, December 2009 , pp. 4085-4086(2)

Publisher: Bentham Science Publishers

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A